Unichem Laboratories has received ANDA approval for its Amitriptyline HCL Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA)
The drug is to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP.
Amitriptyline HCL Tablets are indicated for the relief of symptoms of depression.
The product will be commercialised from Unichem’s Goa Plant.
Also read other approvals:
Alembic gets USFDA Final nod for Lurasidone HCL Tablets
Alembic gets USFDA nod for depression treatment drug
Caplin gets USFDA nod for Neostigmine Methylsulfate Injection
Gilead gets USFDA nod to treat metastatic urothelial cancer
NATCO gets tentative USFDA nod for Ibrutinib tablets
First AI device to help detect colon cancer gets USFDA nod
NPPA fixes retail prices of 2 formulations
Bring Nutraceuticals for prevention of diseases under DCGI’s regulation: Experts to…
Baricitinib: BDR Pharma signs licensing agreement with Lilly
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir
Black Fungus: AIIMS to develop Guidelines for treatment
NPPA directs Pulse Oximeter & Oxygen Concentrators to submit MRP
Subscribe for daily free updates on Telegram
Follow us on Facebook and Linkedin
For daily free updates on WhatsApp, click here